{"id":31652,"date":"2021-06-21T08:09:17","date_gmt":"2021-06-21T08:09:17","guid":{"rendered":"https:\/\/pr.asianetpakistan.com\/?p=75364"},"modified":"2021-06-21T08:09:17","modified_gmt":"2021-06-21T08:09:17","slug":"centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity","status":"publish","type":"post","link":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/","title":{"rendered":"Centrient Pharmaceuticals boosting statins API manufacturing capacity"},"content":{"rendered":"<p>Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) &#8212;<\/p>\n<p>Summary:<\/p>\n<ul>\n<li>Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India.<\/li>\n<li>With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins.<\/li>\n<li>Centrient Pharmaceuticals\u2019 statins are one of the most sustainably produced in the industry by eliminating harmful solvents, generating less waste, and a reduced carbon footprint of 32% as compared to traditional manufacturers.<\/li>\n<li>Using backward integrated manufacturing methods, and dedicated production facilities, Centrient Pharmaceuticals is able to offer its customers security of supply.<\/li>\n<\/ul>\n<p><strong>Centrient Pharmaceuticals (\u201cCentrient\u201d), the global leader in sustainable antibiotics, next-generation statins and anti-fungals, announced today to have started production at its new statins manufacturing unit. With the building of its second<\/strong><b>\u00a0dedicated unit on the Toansa site in India now completed,\u00a0<\/b>t<strong>he company will double its statins production capacity. This will enable Centrient to meet growing demand for its sustainably manufactured Atorvastatin and Rosuvastatin Active Pharmaceutical Ingredients (APIs).<\/strong><\/p>\n<p>Statins are currently the most prescribed drug class globally for the treatment of high cholesterol and cardiovascular diseases and are among the top-selling drugs worldwide. The markets for Atorvastatin and Rosuvastatin in particular, has shown steady growth in the past years, as a result of the continued global prevalence of high cholesterol issues, replacement of older generation statins, and genericization of the market.<\/p>\n<p>Starting almost a decade ago, Centrient has grown today into one of the leading statin API suppliers worldwide, servicing large pharma companies around the globe.<\/p>\n<p>Next to high-quality features like long shelf life and large batch sizes, the company offers security of supply to customers through its dedicated statins production facility and backward integration. Being backward integrated, Centrient is independent from external imports of starting materials. Its enzymatic route of synthesis and patented technology minimise the use of harmful solvents, generate less waste, and reduce the company\u2019s carbon footprint by 32% as compared to traditional manufacturers.<\/p>\n<p>The news of the facility expansion follows major milestones on statins that the company reached in the past years. In 2012, under the name of DSM Sinochem Pharmaceuticals, it was the first pharmaceutical manufacturer worldwide to offer generic Atorvastatin APIs under a Certificate of Suitability to the Monograph of the European Pharmacopoeia (CEP). Since 2014, it has produced the unique Atorvastatin APIs in its state-of-the-art facility in Toansa, India for third-party customers.<\/p>\n<p>In addition, the company was one of the first three companies worldwide that started to offer generic Rosuvastatin APIs under CEP in 2016. Two years later, the first generic Rosuvastatin and Atorvastatin finished dosage forms were launched in Western Europe.<\/p>\n<p><i>\u201cWith the doubling of our production capacity, we demonstrate our commitment\u00a0<\/i><i>to maintain our leadership position in line with our strategy and\u00a0<\/i><i>to continue supporting our customers\u2019 business growth. Guided by\u00a0<\/i><i>our brand promise of Quality, Reliability, and Sustainability, Centrient\u2019s Rosuvastatin and Atorvastatin offer superior performance in all three areas to the benefit of our customers and the environment.<\/i><i>\u201d,<\/i>\u00a0says Frans Vlaar, Chief Commercial Officer at Centrient.<\/p>\n<p>Ground breaking of the new manufacturing unit started at the end of 2019 and commercial supplies from the new unit will start in mid-2021<strong>.\u00a0<\/strong>With the new manufacturing line being operational and doubling the production capacity, Centrient will be even better positioned to secure supply, meeting the growing demand from customers and helping to improve the lives of patients who are in need of these medicine.<\/p>\n<p><i>\u201cWe are extremely proud that we have been able to complete this project in a timely way given the challenges of executing such a complex project in the midst of the COVID pandemic,\u201d<\/i>\u00a0says Jim McPherson, Chief Quality &amp; Technical Operations Officer.\u00a0<i>\u201cIt reinforces our absolute commitment to meet the expectations of our customers as a partner of choice &#8211; delivering reliable and secure supply using leading sustainable technologies. The facility incorporates design features that allow further improvements in GMP and energy utilization, and enable greater automation for improved process control.\u201d<\/i><\/p>\n<p><b>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<wbr \/>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<wbr \/>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<wbr \/>&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;&#8212;<wbr \/>&#8212;&#8212;&#8212;&#8211;<\/b><\/p>\n<p><b><br \/>\nAbout Centrient Pharmaceuticals<\/b><\/p>\n<p>Centrient Pharmaceuticals is the leading manufacturer of beta-lactam antibiotics, and a provider of next generation statins and antifungals. We produce and sell intermediates, active pharmaceutical ingredients and finished dosage forms.<\/p>\n<p>We stand proudly at the centre of modern healthcare, as a maker of essential and life-saving medicines. With our commitment to Quality, Reliability and Sustainability at the heart of everything we do, our over 2200 employees work continuously to meet our customers\u2019 needs. We work towards a sustainable future by actively participating in the fight against antimicrobial resistance.<\/p>\n<p>Founded 150 years ago as the \u2018Nederlandsche Gist- en Spiritusfabriek\u2019, our company was known as Gist Brocades and more recently DSM Sinochem Pharmaceuticals. Headquartered in Rotterdam (Netherlands), we have production facilities and sales offices in China, India, the Netherlands, Spain, Egypt, the United States and Mexico. Centrient Pharmaceuticals is wholly owned by Bain Capital Private Equity, a leading global private investment firm.<\/p>\n<p>For more information please visit\u00a0<a href=\"http:\/\/www.centrient.com\/\"  data-saferedirecturl=\"https:\/\/www.google.com\/url?q=http:\/\/www.centrient.com&amp;source=gmail&amp;ust=1624348806802000&amp;usg=AFQjCNEiIgPKiQNNvB_hjYGAnYlYVTV02A\">www.centrient.com<\/a>\u00a0or contact Centrient Pharmaceuticals Corporate Communications, Alice Beijersbergen, Director Branding &amp; Communications. E-Mail:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=2VMEwioaAdztHtfB8EMWbWyqiG_D1wlN-La9JjQ47bT1bZv4eGUxRr25Z6K-vyct0YOiS8tvKTnGS8tSBhPgMHyWEKpT57jwuk0_13ZFS2sWfj_ONWdqjXm9GzTj3Q2E\"  rel=\"nofollow\" data-saferedirecturl=\"https:\/\/www.google.com\/url?q=https:\/\/www.globenewswire.com\/Tracker?data%3D2VMEwioaAdztHtfB8EMWbWyqiG_D1wlN-La9JjQ47bT1bZv4eGUxRr25Z6K-vyct0YOiS8tvKTnGS8tSBhPgMHyWEKpT57jwuk0_13ZFS2sWfj_ONWdqjXm9GzTj3Q2E&amp;source=gmail&amp;ust=1624348806802000&amp;usg=AFQjCNGkmLHn_deRnBCMoIpGcEBAzKm_4w\">alice.beijersbergen@centrient.<wbr \/>com<\/a>.<\/p>\n<p>Forward-looking statements<br \/>\nThis press release may contain forward-looking statements with respect to Centrient Pharmaceuticals\u2019 future financial performance and position. Such statements are based on current expectations, estimates and projections of Centrient and information currently available to the company. Centrient cautions readers that such statements involve certain risks and uncertainties that are difficult to predict and therefore it should be understood that many factors can cause actual performance and position to differ materially from these statements. Centrient has no obligation to update the statements contained in this press release, unless required by law. The English language version of the press release is governing.<img decoding=\"async\" class=\"CToWUd\" src=\"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=\" alt=\"\" width=\"1\" height=\"1\" \/><\/p>\n<pre>Alice Beijersbergen\nCentrient Pharmaceuticals\n<a href=\"mailto:alice.beijersbergen@centrient.com\" >alice.beijersbergen@centrient.<wbr \/>com<\/a>\n<\/pre>\n","protected":false},"excerpt":{"rendered":"<p>Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) \u2014 Summary: Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India. With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins. Centrient Pharmaceuticals\u2019 statins are one [\u2026]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[97],"tags":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Centrient Pharmaceuticals boosting statins API manufacturing capacity - South Africa Gazette<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Centrient Pharmaceuticals boosting statins API manufacturing capacity - South Africa Gazette\" \/>\n<meta property=\"og:description\" content=\"Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) \u2014 Summary: Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India. With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins. Centrient Pharmaceuticals\u2019 statins are one [\u2026]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\" \/>\n<meta property=\"og:site_name\" content=\"South Africa Gazette\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-21T08:09:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=\" \/>\n<meta name=\"author\" content=\"shadmin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"shadmin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\"},\"author\":{\"name\":\"shadmin\",\"@id\":\"https:\/\/southafricagazette.com\/#\/schema\/person\/ed2a8470fb6dce16b525ad4dffe66cd2\"},\"headline\":\"Centrient Pharmaceuticals boosting statins API manufacturing capacity\",\"datePublished\":\"2021-06-21T08:09:17+00:00\",\"dateModified\":\"2021-06-21T08:09:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\"},\"wordCount\":942,\"publisher\":{\"@id\":\"https:\/\/southafricagazette.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=\",\"articleSection\":[\"Press Releases\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\",\"url\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\",\"name\":\"Centrient Pharmaceuticals boosting statins API manufacturing capacity - South Africa Gazette\",\"isPartOf\":{\"@id\":\"https:\/\/southafricagazette.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=\",\"datePublished\":\"2021-06-21T08:09:17+00:00\",\"dateModified\":\"2021-06-21T08:09:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage\",\"url\":\"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=\",\"contentUrl\":\"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/southafricagazette.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Centrient Pharmaceuticals boosting statins API manufacturing capacity\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/southafricagazette.com\/#website\",\"url\":\"https:\/\/southafricagazette.com\/\",\"name\":\"South Africa Gazette\",\"description\":\"Latest News From South Africa!\",\"publisher\":{\"@id\":\"https:\/\/southafricagazette.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/southafricagazette.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/southafricagazette.com\/#organization\",\"name\":\"South Africa Gazette\",\"url\":\"https:\/\/southafricagazette.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/southafricagazette.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/southafricagazette.com\/wp-content\/uploads\/2021\/02\/cropped-586d309f-5e3f-49c8-8240-6a4c15978b8a_200x200.png\",\"contentUrl\":\"https:\/\/southafricagazette.com\/wp-content\/uploads\/2021\/02\/cropped-586d309f-5e3f-49c8-8240-6a4c15978b8a_200x200.png\",\"width\":200,\"height\":110,\"caption\":\"South Africa Gazette\"},\"image\":{\"@id\":\"https:\/\/southafricagazette.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/southafricagazette.com\/#\/schema\/person\/ed2a8470fb6dce16b525ad4dffe66cd2\",\"name\":\"shadmin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/southafricagazette.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g\",\"caption\":\"shadmin\"},\"url\":\"https:\/\/southafricagazette.com\/author\/shadmin-s\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Centrient Pharmaceuticals boosting statins API manufacturing capacity - South Africa Gazette","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/","og_locale":"en_US","og_type":"article","og_title":"Centrient Pharmaceuticals boosting statins API manufacturing capacity - South Africa Gazette","og_description":"Rotterdam, The Netherlands, June 21, 2021 (GLOBE NEWSWIRE) \u2014 Summary: Centrient Pharmaceuticals has started production at its newly built statins API manufacturing unit in Toansa, India. With this expansion the company is doubling its production capacity of Atorvastatin and Rosuvastatin, meeting the increased demand for its high-quality uniquely produced statins. Centrient Pharmaceuticals\u2019 statins are one [\u2026]","og_url":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/","og_site_name":"South Africa Gazette","article_published_time":"2021-06-21T08:09:17+00:00","og_image":[{"url":"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg="}],"author":"shadmin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"shadmin","Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#article","isPartOf":{"@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/"},"author":{"name":"shadmin","@id":"https:\/\/southafricagazette.com\/#\/schema\/person\/ed2a8470fb6dce16b525ad4dffe66cd2"},"headline":"Centrient Pharmaceuticals boosting statins API manufacturing capacity","datePublished":"2021-06-21T08:09:17+00:00","dateModified":"2021-06-21T08:09:17+00:00","mainEntityOfPage":{"@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/"},"wordCount":942,"publisher":{"@id":"https:\/\/southafricagazette.com\/#organization"},"image":{"@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage"},"thumbnailUrl":"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=","articleSection":["Press Releases"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/","url":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/","name":"Centrient Pharmaceuticals boosting statins API manufacturing capacity - South Africa Gazette","isPartOf":{"@id":"https:\/\/southafricagazette.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage"},"image":{"@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage"},"thumbnailUrl":"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=","datePublished":"2021-06-21T08:09:17+00:00","dateModified":"2021-06-21T08:09:17+00:00","breadcrumb":{"@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#primaryimage","url":"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg=","contentUrl":"https:\/\/ci6.googleusercontent.com\/proxy\/G9868Y_1gOf3ZXwMgHDnMq7FO7K3Mqx_82jIQv4mcmKcbj-Svpc71lwmRKRpqStmQhEQ66_LJdeXIEFnADBFylOXSBkngMMBqooJ1vYlnw5pEiqSIj2nujSQH2NbjjBz=s0-d-e1-ft#https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI1NzQ1MSM0MjUxMjI0IzIxOTAwNzg="},{"@type":"BreadcrumbList","@id":"https:\/\/southafricagazette.com\/centrient-pharmaceuticals-boosting-statins-api-manufacturing-capacity\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/southafricagazette.com\/"},{"@type":"ListItem","position":2,"name":"Centrient Pharmaceuticals boosting statins API manufacturing capacity"}]},{"@type":"WebSite","@id":"https:\/\/southafricagazette.com\/#website","url":"https:\/\/southafricagazette.com\/","name":"South Africa Gazette","description":"Latest News From South Africa!","publisher":{"@id":"https:\/\/southafricagazette.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/southafricagazette.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/southafricagazette.com\/#organization","name":"South Africa Gazette","url":"https:\/\/southafricagazette.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/southafricagazette.com\/#\/schema\/logo\/image\/","url":"https:\/\/southafricagazette.com\/wp-content\/uploads\/2021\/02\/cropped-586d309f-5e3f-49c8-8240-6a4c15978b8a_200x200.png","contentUrl":"https:\/\/southafricagazette.com\/wp-content\/uploads\/2021\/02\/cropped-586d309f-5e3f-49c8-8240-6a4c15978b8a_200x200.png","width":200,"height":110,"caption":"South Africa Gazette"},"image":{"@id":"https:\/\/southafricagazette.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/southafricagazette.com\/#\/schema\/person\/ed2a8470fb6dce16b525ad4dffe66cd2","name":"shadmin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/southafricagazette.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ff4aa10d4f36ab9dc3cce9e101792273?s=96&d=mm&r=g","caption":"shadmin"},"url":"https:\/\/southafricagazette.com\/author\/shadmin-s\/"}]}},"_links":{"self":[{"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/posts\/31652"}],"collection":[{"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/comments?post=31652"}],"version-history":[{"count":0,"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/posts\/31652\/revisions"}],"wp:attachment":[{"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/media?parent=31652"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/categories?post=31652"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/southafricagazette.com\/wp-json\/wp\/v2\/tags?post=31652"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}